Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPH - Cytoclonal Pharmaceutics -- Ignore unavailable to you. Want to Upgrade?

To: Axxel who wrote (217)	7/1/1998 8:25:00 AM
From: Doug Coughlan	Respond to of 428

I'm afraid that you misinterpreted my remarks. I didn't say that JM was not a legitimate firm. For some reason you interpreted it that way. In fact I spoke to Bruce Meyers yesterday. Never the less, it would be better for all concerned if a brokerage house with no connection to CYPH issued a "strong buy" recommendation.

To: Axxel who wrote (217)	7/1/1998 11:20:00 AM
From: Sir Auric Goldfinger	Read Replies (1) \| Respond to of 428

Oh sure, dis-interested party: Peter Janssen files to sell 50,000 shares on 6/29/98 (that's on you Bloomberg too,why don't you say that?) As well, you might view JANS as a reputable firm, but I do not. They and their deals (CCSI,MCHM CYPH, et al) are front and center in the Dreyfus Aggressive Growth/Schonberg scandal. There are bound to have serious investigative activity going on if they don't already. They are a "pump and dump" bucket shop in no uncertain terms. CYPH is a joke and anybody following the unravelling of this scheme is either a) selling to get out of the downward cascade or if they are aggressive enough b) shorting all they can borrow. All of the above in my opinion. All rights reserved, Auric Goldfinger.